Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRO40303 for reduction of reperfusion injury during PCI in acute myocardial infarction
2010-024616-33Phase 2Completed
- Sponsor
- Trophos
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) and myocardial ischemia-reperfusion injury comparing TRO40303 with Placebo (2 arms). Primary endpoints: Infarct size by creatine kinase area under the curve and Infarct size by troponin I area under the curve. Started Jul 2011; status: completed.
02
Drugs
TRO40303
03
Conditions
myocardial infarction (MI)myocardial ischemia-reperfusion injury
Beyond the preview
Go deeper on 2010-024616-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024616-33.